Yuki Ishibashi

Showing 1-8 of 8 articles

Coronary interventions

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

Nakatani S, Sotomi Y, Ishibashi Y, Grundeken M.J, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu M, Räber L, Bezerra H, Costa M, Fitzgerald P, Prati F, Costa R, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys P, Onuma Y

December 20, 2016 | 10.4244/EIJY15M10_03

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study

Nakatani S, Onuma Y, Ishibashi Y, Karanasos A, Regar E, Garcia-Garcia H, Tamburino C, Fajadet J, Vrolix M, Witzenbichler B, Eeckhout E, Spaulding C, Reczuch K, La Manna A, Spaargaren R, Capodanno D, van Langenhove G, Verheye S, Serruys P, van Geuns R

December 20, 2015 | 10.4244/EIJY15M11_01

Definite and probable bioresorbable scaffold thrombosis in stable and ACS patients

Ishibashi Y, Nakatani S, Onuma Y

July 20, 2015 | 10.4244/EIJY14M09_08

Coronary interventions

The need for dedicated bifurcation quantitative coronary angiography (QCA) software algorithms to evaluate bifurcation lesions

Grundeken M.J, Ishibashi Y, Ramcharitar S, Tuinenburg J, Reiber J, Tu S, Aben J, Girasis C, Wykrzykowska J, Onuma Y, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA10

Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial

Nakatani S, Onuma Y, Ishibashi Y, Muramatsu T, Iqbal J, Zhang Y-J, van Geuns R, Ormiston J, Serruys P

March 20, 2015 | 10.4244/EIJV10I11A218

Fast virtual functional assessment of intermediate coronary lesions using routine angiographic data and blood flow simulation in humans: comparison with pressure wire – fractional flow reserve

Papafaklis M, Muramatsu T, Ishibashi Y, Lakkas L, Nakatani S, Bourantas C, Ligthart J, Onuma Y, Echavarría-Pinto M, Tsirka G, Kotsia A, Nikas D, Mogabgab O, van Geuns R, Naka K, Fotiadis D, Brilakis E, Garcia-Garcia H, Escaned J, Zijlstra F, Michalis L, Serruys P

September 28, 2014 | 10.4244/EIJY14M07_01

Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial

Ishibashi Y, Onuma Y, Muramatsu T, Nakatani S, Iqbal J, Garcia-Garcia H, Bartorelli A, Whitbourn R, Abizaid A, Serruys P

August 19, 2014 | 10.4244/EIJV10I4A78

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....

Coronary flow capacity: where to next?

Nils P. Johnson

Joint EAPCI/ACVC expert consensus document on pVADs

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease